CenterBook Partners LP increased its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 149.7% in the 4th quarter, Holdings Channel reports. The firm owned 9,799 shares of the company’s stock after buying an additional 5,874 shares during the period. CenterBook Partners LP’s holdings in Addus HomeCare were worth $1,052,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Global Retirement Partners LLC boosted its holdings in Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the last quarter. Larson Financial Group LLC raised its stake in Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares during the last quarter. Private Trust Co. NA lifted its holdings in shares of Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after buying an additional 112 shares during the period. AlphaQuest LLC bought a new position in shares of Addus HomeCare during the 3rd quarter valued at $37,000. Finally, Wexford Capital LP purchased a new position in shares of Addus HomeCare in the 3rd quarter worth $41,000. Institutional investors own 95.35% of the company’s stock.
Addus HomeCare Price Performance
NASDAQ ADUS opened at $93.17 on Thursday. The business’s fifty day moving average is $93.75 and its 200 day moving average is $103.52. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The company has a market capitalization of $1.74 billion, a PE ratio of 17.22, a price-to-earnings-growth ratio of 1.27 and a beta of 0.89.
Wall Street Analyst Weigh In
Several brokerages recently commented on ADUS. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Weiss Ratings downgraded Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd. Barclays dropped their target price on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $131.00.
Check Out Our Latest Report on Addus HomeCare
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
- Five stocks we like better than Addus HomeCare
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
